Dr Natalia Schütz speaks to ecancer about the use of bispecifics and CAR T cells in South America.

Latin America struggles with accessing innovative treatments like CAR T cells due to high costs and poor infrastructure.

Government health policies play a role in this limited access. While Brazil is making progress, specialised facilities are still needed.

Educating healthcare providers and patients is vital for safe treatment delivery.

Community collaboration is key to advocating for better access and sharing patient experiences.